Home

Gurnet Point Capital

Investments | Gurnet Point Capital

Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and Christopher A. Viehbacher. Its long-term capital, deployed by a highly experienced team, aims to enable a new generation of companies to grow and to unlock innovative and transformational healthcare solutions Founded by Ernesto Bertarelli and Christopher A. Viehbacher, Gurnet Point Capital is a healthcare investment fund based in Cambridge, Massachusetts, USA. It invests in life sciences and medical technologies as well as healthcare services across all stages of development through to commercialization. www.gurnetpointcapital.co Management of the family's wealth is mainly through the Waypoint Capital group, which invests through its owned-businesses that are active in asset management, including real estate, and healthcare. These businesses include Kedge Capital, an investment management group specialising in hedge funds, private equity and real estate; Northill Capital, an asset management business; a UK real estate investment fund, Crosstree; and Gurnet Point Capital, a fund based in Boston that invests.

Contact Email info@gurnetpointcapital.com Phone Number 617-588-4900 They partner with life science leaders who have the vision and drive to transform their businesses. Those leaders are born risk-takers Chris Viehbacher (born 1960) is a German - Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher is currently Managing Partner of Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family Interessant ist auch Beratrelli's Biotech-Investmentfirma Gurnet Point Capital, die 2015 als Hauptinvestor Boston Pharmaceuticals gegründet hat. Boston Pharmaceuticals verfügte von Anfang an über 600 Millionen Dollar. Im Jahr 2018 erwarb die US-Pharmafirma drei verschiedene Medikamentenlizenzen von Novartis und GlaxoSmithKline. Der Kopf hinter den strategischen Investitionen war der. Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision. Gurnet Point Capital | 496.

Gurnet Point Capital Waypoint Capita

  1. Gurnet Point Capital Nachrichten Gurnet Point Capital unter +1 617 588 4900 anrufen ode
  2. Gurnet Point Capital Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation
  3. Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today that the following clinical trials have been initiated to support a label expansion of its FDA-approved innovative collagen drug-device, XARACOLL (bupivacaine hydrochloride) implant:INN-CB-024 is phase 3 randomized, double-blind, placebo-controlled study to evaluate.
  4. Chaired by Ernesto Bertarelli, Waypoint and the businesses created by it manage investments in healthcare, medical technologies and asset management, including real estate. Headquartered in Geneva, it has offices in London, Jersey, Boston and Luxembourg
  5. Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Christopher Viehbacher who, together, have decades of expertisein an industry for which they share a passion, both as Chief Executives and as investors
  6. Boston Pharmaceuticals is a portfolio company of Gurnet Point Capital, a Cambridge, MA based private equity firm focused on healthcare investing. For more information, please visit www.bostonpharmaceuticals.com or follow us on Twitter @BosPharma and LinkedIn. Contacts MacDougall Kari Watson or Emily Wong bostonpharmaceuticals@macbiocom.com 781-235-3060. More News. vCita Secures $15M Growth.
  7. Specialty pharmaceutical company KemPharm, Inc. amended its collaboration and licensing agreement with an affiliate of Gurnet Point Capital (GPC). The latter is a private equity firm with a focus.

Gurnet Point Capital Bertarell

  1. Travis Wilson is an investment partner at Gurnet Point Capital, a global healthcare fund focused on growth equity and venture opportunities in the life sciences. Previously, he was the President and CEO of Stealth BioTherapeutics, a late-stage clinical biotechnology company developing therapies to treat mitochondrial dysfunction in common and rare diseases. Travis has extensive experience in.
  2. Gurnet Point Capital LCC operates as a venture capital firm. The Company invests in life science and pharmaceutical companies. Gurnet Point Capital serves customers in the United States
  3. Gurnet Point Capital Names David Moore Partner Business Wire CAMBRIDGE, Mass. -- February 24, 2020 Gurnet Point Capital (Gurnet Point), a private investment firm focused on health care.

Ernesto Bertarelli - Wikipedi

Gurnet Point Capital 2013 - 2018 5 years. $2B life sciences growth equity and venture capital fund backed by Waypoint Capital Senior Associate Third Rock Ventures. People. The talents of the people at Waypoint cover a broad range of disciplines and its leaders, as well as those of its businesses, are committed to entrepreneurship and to innovation. Waypoint's most important strategic imperative is that it recognises the importance of investing in and developing its people. Vice-Chairman and Non-Executive. U.S. investment firm Gurnet Point Capital is nearing a deal to acquire Ireland-based specialty drugmaker Innocoll Holdings Plc, people familiar with the matter said on Tuesday. The deal would add. Christopher Viehbacher ist derzeit Managing Partner bei Gurnet Point Capital, Chairman of the Board bei PureTech und Director bei Zikani Therapeutics. Bei Gurnet Point Capital hat Christopher Viehbacher 3 Kollegen einschließlich David Moore (Partner), Travis Wilson (Partner),. Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Chris Viehbacher, who together have decades of expertise in an industry for which they share a passion.

Gurnet Point Capital - Crunchbase Investor Profile

  1. As previously announced, Corium, Inc. (Corium), a portfolio company of Gurnet Point Capital, is leading U.S. commercialization efforts for AZSTARYS. Corium is led by Perry Sternberg, President and.
  2. U.S. investment firm Gurnet Point Capital is nearing a deal to acquire Ireland-based specialty drugmaker Innocoll Holdings Plc <INNL.O>, people familiar with the matter said on Tuesday
  3. In addition, Gurnet Point Capital has made an investment in Pronutria, the fund's first announced investment, completing Pronutria's Series C financing. The terms of the investment were not disclosed. We are honored to have Chris join our board and are thrilled to welcome Gurnet Point into our investor syndicate, said Robert Connelly, President and Chief Executive Officer at Pronutria.
  4. CAMBRIDGE, Mass. - November 19, 2015 : Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christopher A. Viehbacher, today announced the creation of Boston Pharmaceuticals, a fully-integrated drug development company that will offer an innovative alternative model for drug development and.
  5. Gurnet Point Capital invests across all stages of product development through to commercialization, and represents a hybrid of venture and private equity investment strategies. These strategies.
  6. Gurnet Point Capital. Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation.see more He is also a member of the boards of a number of companies including PureTech Health plc. He is a member of the Board of Trustees of Northeastern University and a member.
  7. Welcome. Chaired by Ernesto Bertarelli, Waypoint and the businesses created by it manage investments in healthcare, medical technologies and asset management, including real estate. Headquartered in Geneva, it has offices in London, Jersey, Boston and Luxembourg. About Waypoint

Investment Analyst at Gurnet Point Capital Cambridge, Massachusetts, United States 476 connections. Join to Connect Gurnet Point Capital. University of Pennsylvania. Report this profile. Gurnet Point Capital Gurnet Point Capital Investment Management DCI Engineers DCI Engineers Civil Engineering Seattle, WA Clavalo Construction, Inc. Boston Pharmaceuticals is a portfolio company of Gurnet Point Capital, a Cambridge, MA based private equity firm focused on healthcare investing. For more information, please visit www.bostonpharmaceuticals.com or follow us on Twitter @BosPharma and LinkedIn. Contacts MacDougall Kari Watson or Emily Wong bostonpharmaceuticals@macbiocom.com 781-235-3060. More News. Gurnet Point Capital Leads. Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christopher A. Viehbacher, has announced the creation of Boston Pharmaceuticals, a fully-integrated drug development company that will offer an innovative alternative model for drug development and commercialisation Most searched biographies at Gurnet Point Capital. Christopher Viehbacher, Managing Partner; David Moore, Partner; Travis Wilson, Partner; Click on an executive to view his biography > Latest M&A news in Fund. SS&C Technologies has announced the acquisition of Mainstream (posted on May 28, 2021). Mattioli Woods has announced the acquisition of Maven Capital (posted on May 28, 2021). Sports.

CONCORD, Mass., December 9, 2020 -- Tremeau Pharmaceuticals announced today that Gurnet Point Capital has agreed to fund the clinical development of its investigational drug TRM-201 (rofecoxib), including a Phase III trial of TRM-201 for hemophilic arthropathy (HA). Gurnet Point Capital, a private investment firm focused on the healthcare and life sciences sectors, is Tremeau's primary. Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Chris Viehbacher, who, together, have decades of expertise in an industry for which they share a passion, both as Chief Executives and as investors. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in building a new generation of companies. Based in.

Gurnet Point Capital participates, on average, in 15 percentage points less than the average amount of lead investments in other funds. Moreover, a start-up needs to be 4-5 years old to get investment from this fund. The country of its foundation and the country of its most frequent investments coincides - United States. BEFORE Brands, Axcella are amongst the various portfolio companies of. Gurnet Point Capital | 494 Follower auf LinkedIn Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision

Former Sanofi CEO Viehbacher takes health investment role

U.S. investment firm Gurnet Point Capital is nearing a deal to acquire Ireland-based speciality drugmaker Innocoll Holdings Plc <INNL.O>, people familiar with the matter said on Tuesday Gurnet Point Capital. We partner with life science leaders who have the vision and drive to transform their businesses. Those leaders are born risk-takers. Original thinkers with big ideas and bigger ambitions. Explorers who question the status quo. They are driven to succeed and are uncompromising in their quest to make things happen, even if the solutions aren't easy or obvious. They are. KemPharm Inc (NASDAQ: KMPH) has amended the collaboration and license agreement with Gurnet Point Capital (GPC), a private investment firm.; The agreement provides for an exclusive worldwide.

Find out which companies Gurnet Point Capital is investing in, as well as the disease indication and therapeutic approach of every investment! Home. PRO Data . PRO Dashboards. Neuro Insights $27B+ Gene Therapy Insights $19B+ Autoimmune Insights $24B+ COVID-19 Insights $7.5B+ Metabolic Disorders $15B+ Clinical Dashboards . Clinical Dashboards. Neuro Insights $27B+ Gene Therapy Insights $19B. Corium, Inc. (Corium), a portfolio company of Gurnet Point Capital (GPC), is leading the commercialization of AZSTARYS and expects to make AZSTARYS commercially available in the U.S. as early as.

Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Christopher Viehbacher, who,together, have decades of expertise in an industry for which they share a passion, both as Chief Executives and asinvestors. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in buildinga new generation of companies. Based.

Gurnet Point Capital Launches Boston Pharmaceuticals with

Mr. Moore joined Gurnet Point Capital in early 2020. Prior to joining Gurnet Point, he was the Chief Executive Officer of one of the infectious disease businesses of Roivant Sciences, a biopharmaceutical drug development company. Before his role at Roivant, Mr. Moore was Senior Vice President, Commercial, at Novo Nordisk US, where he led the successful transformation of the company's. Gurnet Point Capital (Gurnet Point) today announced that Dr. Sophie Kornowski is to be appointed as Senior Partner. Dr. Kornowski currently serves Tremeau has received funding from Gurnet Point Capital for the clinical development of TRM-201 (rofecoxib) to treat hemophilic arthropathy (HA)

Chris Viehbacher - Wikipedi

Kailas Salunkhe - April 9, 2021, 8:08 AM EDT. Specialty pharmaceutical company KemPharm, Inc. amended its collaboration and licensing agreement with an affiliate of Gurnet Point Capital (GPC). The. Corium International shares soar on buyout deal with privately held Gurnet Point Capital. The buyers will pay $12.50 per share at the closing of the agreement and another treatment if its lead drug to treat Alzheimer's wins approval before March 31, 2020. Corium International, which is developing a drug for Alzheimers, was bought out by an. Boston Pharmaceuticals wurde im Jahr 2015 von Gurnet Point Capital gegründet und mit 600 Mio. $ ausgestattet, der Investmentfonds Gurnet startete im Jahr 2014 mit einem Grundkapital von 2 Mrd. Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation. He is also a member of the boards of a number of companies including PureTech Health plc. He is a member of the Board of Trustees of Northeastern University and a member of the Board of Fellows of the.

Neuer CEO für Investmentfirma von schweizer Bertarelli

Fereydoun is the Managing Partner of Gurnet Point Capital and oversees the U.S. life sciences investment platform. Prior to joining Gurnet Point Capital, Fereydoun was President and CEO of Merck Serono U.S., Head of the Global Fertility and Endocrinology Business Unit, and a member of the Executive Management Board of Merck Serono KemPharm Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS 11.03.21 KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Result

Gurnet Point Capital LinkedI

Gurnet Point Capital. Jul 2014 - Present6 years 9 months. Cambridge, MA Gurnet Point Capital | 490 abonnés sur LinkedIn. Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision The Gurnet, Plymouth, MA. 633 likes · 9 talking about this · 1,338 were here. Named by the English perhaps after the Gurnet fish, Gurnet Point was once covered in pine trees. Among the oldest.. About Gurnet Point Capital. Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Christopher Viehbacher, who, together, have decades of expertise in an industry for which they share a passion, both as Chief Executives and as investors. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in building a new. About Gurnet Point Capital Gurnet Point Capital (GPC) is a unique healthcare fund founded by Ernesto Bertarelli and led by Christopher A. Viehbacher, who, together, have decades of expertise in an.

Organigramm Gurnet Point Capital - The Official Boar

Gurnet Point Capital (GPC) is a unique health care fund founded by Ernesto Bertarelli and led by Christopher A. Viehbacher, who, together, have decades of expertise in an industry for which they. Mr. Moore joined Gurnet Point Capital in early 2020. Prior to joining Gurnet Point, he was the Chief Executive Officer of one of the infectious disease businesses of Roivant Sciences, a biopharmaceutical drug development company. Before his role at Roivant, Mr. Moore was Senior Vice President, Commercial, at Novo Nordisk US, where he led the successful transformation of the company's.

Zikani Therapeutic

James Singleton is General Counsel (US) for Waypoint Capital, which focuses on investments in the healthcare and life science sectors, and asset management in private equity, hedge funds, real estate and fund-of-funds investments. James also serves as General Counsel for Waypoint's affiliate Gurnet Point Capital, a global healthcare fund focused on the healthcare and life sciences sectors. Gurnet Point Capital. Dieses Profil melden Berufserfahrung Senior Partner Gurnet Point Capital Aug. 2018 -Heute 2 Jahre 10 Monate. Boston, Massachusetts, United States Roche 11 Jahre 5 Monate Global Head of Roche Partnering Roche Feb. 2012 -. Macrolide Pharmaceuticals, Inc. launched with a Series A financing of $22 million led by Novartis Venture Fund, Gurnet Point Capital, Roche Ventures

Gurnet Point Capital Follow[dot]Healt

Gurnet Point Capital is a unique healthcare fund founded by Ernesto Bertarelli and led by Chris Viehbacher, who, together, have decades of expertise in an industry for which they share a passion. Garnet Capital is a financial services company specializing in managing loan portfolio sales and providing valuation services. Read More. Garnet Blog. Banks Are Sitting on Cash But Hesitant to Lend June 17, 2021 The COVID-19 pandemic has had devastating effects on many people and companies. Ordinarily, in a crisis, you would expect banks to extend more loans to cash-strapped consumers. However. Gurnet Point Capital - Investments, Portfolio & Company Exits Founded - Founders. Search. Overview. Unlock datapoints. Portfolio analytics. Team. Investments. News & Media. Add fund to favorites. Save this fund for later to form your own custom list of funds. This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not. Gurnet Point Capital (GPC) is a unique health care fund founded by Ernesto Bertarelli and led by Christopher A. Viehbacher, who, together, have decades of expertise in an industry for which they share a passion, both as Chief Executives and as investors. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in building a new generation of. Check Gurnet Point Capital's profile on ExecLibrary, current management team, past employees information, social channels, interesting news for target accounts and competitors and customized research

News | Gurnet Point CapitalGurnet Point L

Gurnet Point Capital Limited is private equity and venture capital firm. Search Crunchbase. Advanced Search. Try Pro free Solutions. Products. Resources. Resources. Pricing. Log In. Investment Firm. Gurnet Point Capital. Connect to CRM . Save . Summary Financials Investments People Technology Signals & News. Highlights.

Healthcare fund Gurnet Point buys Innocoll&#39;s bioresorbable
  • Spinia Casino Erfahrungen.
  • Ubuntu server Raspberry Pi wifi setup.
  • EUR/USD Volumen.
  • MTU Tradegate.
  • Gewerbeanmeldung Tätigkeitsbeschreibung Handel.
  • Legendware V4 crack.
  • Trezor Exodus.
  • Oyster Protocol.
  • Bitstamp Überweisung Dauer.
  • Verlustbescheinigung Aktien muster.
  • Insättningsgaranti bostadsrättsförening.
  • Zitate neue Wege.
  • Colman Holsteiner.
  • NEE stock split.
  • Youtube etfs explained.
  • Welches Fest feiern die Schweden im Sommer.
  • Terracotta Army 5 oz.
  • Monte Original.
  • The Graph News.
  • Reef Finance roadmap.
  • Neutral funds.
  • Long Strategie.
  • Rapala stock.
  • TikTok Welcher Star filter.
  • YFI buy.
  • Bitcoin companies in Australia.
  • PokerStars Home Games Mobile.
  • Csgo Zeus.
  • EDEKA Paschmann Oberhausen.
  • Steam Geschenk Kopie.
  • Cs:go skins für echtgeld verkaufen 2021.
  • Autotrader buyer protection.
  • Banner erstellen App.
  • Chefs Culinar Umsatz 2019.
  • SafePal Coin.
  • Nähkurs mit Zertifikat.
  • Gigabyte Z490 Vision G Test.
  • Industrial products industry.
  • TradeATF Hello Peter.
  • BoKlok Helsingborg.
  • Gangsta magic steam.